Brief: Nanexa Receives Clinical Trial Approval For NEX-18

Nanexa AB

10/12/2020 13:31

Dec 10 (Reuters) - Nanexa AB  NANEXA.ST :
    * NANEXA RECEIVES CLINICAL TRIAL APPROVAL FOR NEX-18
    * COMPANY HAS RECEIVED PERMISSION TO START CLINICAL TRIAL
FOR DRUG
CANDIDATE NEX-18 BY SWEDISH MEDICAL PRODUCTS AGENCY,
LÄKEMEDELSVERKET.
    * WE EXPECT TO COMPLETE STUDY IN Q3 OF NEXT YEAR

Source text for Eikon:  ID:nMFN5bNCWy 
Further company coverage:  NANEXA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))